gathering segments of the visit is both appropriate and expected by patients. Although this process may seem counterintuitive, if you do not enter information into the computer from time to time, you risk patients questioning how seriously you take their concerns. Timing is everything.
Share | The computer is a wonderful source of information and patients appreciate it when they feel like they are partners in the care process. Turning the computer screen so patients can see what you are typing has the double benefit of partnership and serves as a way to check that what is being typed is what was said or meant.
Educate | The computer screen is also useful as a teaching aid. With a click of the mouse, information such as a patient's weight, blood pressure, and blood glucose measurements can be shown as a histogram and become the basis for a conversation either reinforcing good health habits or talking about how to improve them.
Debrief | Do not take for granted that instructions to patients are clear and perfectly understood. Examination room computers provide the perfect opportunity to use a "teach back" or a "talk back" format to assess the degree to which recommendations are understood.
Being POISED for examination room computer use need not cost additional visit time. Used well, just the opposite is true. Medicine is fundamentally a human enterprise that is still practiced one conversation at a time. The study by Ratanawongsa et al 2 reminds us that our most vulnerable patients may be at even greater risk than others when a disproportionate amount of a physician's time is spent interacting with the computer screen and not with the patient. It is said that technology is neither good nor bad, but it is not neutral. Our challenge is to find the best ways to incorporate computers in the examination room without losing the heart and soul of medicine: the physician-patient relationship.
Richard M. Frankel, PhD Abbreviations: AMI, acute myocardial infarction (MI); CABG, coronary artery bypasses graft; CAD, coronary artery disease; CCI, chronic coronary insufficiency; CKD, chronic kidney disease; HF, heart failure; PA, pulmonary artery. dations, we examined contemporary trends in the use of PA catheterization in patients hospitalized with HF.
Methods | Using survey analysis in the National Inpatient Sample, 3 we identified 2 492 284 adult patients (aged >18 years) eters with procedure codes 89.63, 89.64, 89.66, 89.67, and 89.68 5 while excluding hospitalizations in which PA catheterization may have been used for monitoring in a surgical procedure, mechanical circulatory support was used, and rightsided heart catheterization was performed without PA catheter use. The study was approved by the institutional review board of the University of Iowa, which waived the requirement for informed consent because the study used deidentified data. We analyzed the data from January 1, 2011, through December 31, 2012. We examined calendar-year changes in the use of PA catheters among patients with a primary diagnosis of HF, focusing on the period before (2001-2006) and after (2006-2012) the ESCAPE trial. 1 We also examined trends in hierarchical subgroups consisting of cardiogenic shock, requirement of mechanical ventilation without cardiogenic shock, and HF without cardiogenic shock or respiratory failure.
Results | During the study period, we identified 15 786 patients translating to 75 209 HF hospitalizations with PA catheter use nationally (0.6% of all HF hospitalizations). Baseline characteristics of patients undergoing PA catheter placement changed over time, with a decrease in the mean age, incidence of acute myocardial infarction and cardiac arrest, and use of mechanical ventilation (Table) . First, the study itself deserves comment. The key findings are expressed as rates, and rates are as affected by changes in the denominator as in the numerator. Although the numerator, PA catheter use, may be somewhat discrete and accurately counted, the denominator is more challenging. Changes in the epidemiology and management of heart failure and in hospital coding may all affect the annual type and number of cases counted in the denominator. The changes in rates were reasonably similar to the changes in the number of catheters used, suggesting the numbers in the denominator did not change too dramatically. However, the authors also note that the mix of patients in whom a PA catheter was placed changed considerably over time. We do not know whether the casemix of the denominator also changed or whether physicians were selecting different patients over time.
Second, what is the right rate of PA catheter use? When the negative RCT findings were followed by falling use, one could conclude that all was well: An intervention shown to have no value was fading from practice. However, these new data suggest that, at a minimum, a stubborn and reasonably high rate of PA catheter use persists, despite the lack of evidence of benefit and despite the known costs and potential complications. Two broad schools of thought apply. One defends ongoing practice and argues that many physicians make clever use of the data generated from the catheter to provide highquality care. This school argues that diagnostic strategies are not the same as therapeutic strategies and that the PA catheter is only as good as the user of the information it provides. Although the RCT findings were negative, the RCTs asked narrow questions and did not exclude the benefit provided by smart physicians providing nuanced care in isolated instances. The opposing school states that diagnostic tests should be subject to scrutiny for efficacy and demands that proponents of the PA catheter outline the interventions that would be enacted as a consequence of information generated from the catheter. Thus, they would ask what those smart decisions are and whether physicians can reproduce them.
Both arguments have merits. First, interventions with no merit should be dropped from practice, especially if associated with harm or cost. Second, the definition of no merit is slippery. Although they are our best instrument for inferring causality, RCTs are crude instruments not well suited to determine small benefits from complex interventions in carefully chosen patients. Finally, although we ought to be utilitarian in our assessment of all tests and interventions, physicians struggle to bring the same scrutiny to elements of their existing armamentarium with which they are comfortable and feel expert as to those not yet approved. Here, physicians' instincts may be that adherence to traditional care is conservative, although this argument is likely flawed.
What is the way out of this conundrum? From the societal perspective, a reasonable plan might be to ask proponents of the PA catheter to delineate those practices they consider potentially beneficial. This deliberation should consider alternative strategies that might yield the same gains, such as the use of noninvasive monitoring devices. Next, a plan to test these strategies that would satisfactorily rule out any minimally important differences ought to be developed and priced. Ideally, a value of information framework could be applied to consider the current incremental costs associated with PA catheter use and the cost of further evaluation. Under this framework, if the price is acceptable in terms of national funding priorities, then the catheter should be evaluated, letting the chips fall where they may. However, if the evaluation is too expensive, we may be forced to tolerate the existing uncertainty, which would mean at a minimum circumscribing the set of clinical instances when a PA catheter may be beneficial and explicitly outlining the way proponents use data from the catheter to guide care. This information could be used to control indiscriminate use of the PA catheter and, in clinical settings of unknown but potential value, to help decision making by patients, families, and physicians. 
